Title:
CARBONYL FUSED HETEROCYCLIC DERIVATIVE USED AS UBIQUITIN-SPECIFIC PROTEASE INHIBITOR
Document Type and Number:
WIPO Patent Application WO/2024/061213
Kind Code:
A1
Abstract:
The present invention provides a carbonyl fused heterocyclic derivative used as a ubiquitin-specific protease inhibitor, and specifically relates to a compound represented by formula (I), an isomer thereof, or a pharmaceutically acceptable salt thereof.
Inventors:
LIU BAOMIN (CN)
DAI ZONGHAO (CN)
HU JINFA (CN)
HUANG YU (CN)
DAI ZONGHAO (CN)
HU JINFA (CN)
HUANG YU (CN)
Application Number:
PCT/CN2023/119722
Publication Date:
March 28, 2024
Filing Date:
September 19, 2023
Export Citation:
Assignee:
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD (CN)
International Classes:
C07D487/04; A61K31/519; A61P35/00; C07D413/14; C07D417/14; C07D473/00
Domestic Patent References:
| WO2023143424A1 | 2023-08-03 | |||
| WO2023083285A1 | 2023-05-19 | |||
| WO2022216820A1 | 2022-10-13 | |||
| WO2021163530A1 | 2021-08-19 | |||
| WO2022174184A1 | 2022-08-18 |
Foreign References:
| CN108473495A | 2018-08-31 | |||
| CN113164485A | 2021-07-23 |
Attorney, Agent or Firm:
LINDA LIU & PARTNERS (CN)
Download PDF:
Previous Patent: DATA STORAGE METHOD AND APPARATUS
Next Patent: PIEZOELECTRICALLY DRIVEN SHUTTER, LENS MODULE AND PHOTOGRAPHIC DEVICE
Next Patent: PIEZOELECTRICALLY DRIVEN SHUTTER, LENS MODULE AND PHOTOGRAPHIC DEVICE